MedPath

Effects of near-infrared spectroscopy (NIRS) - neurofeedback on emotion regulation in patients with self-injurious behavior (SI): a pilot study

Not Applicable
Conditions
on-suicidal self-injury syndrome (DSM-5)
X84
Intentional self-harm by unspecified means
Registration Number
DRKS00017557
Lead Sponsor
Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie der Universität Regensburg am Bezirksklinikum Regensburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting withdrawn before recruiting started
Sex
Female
Target Recruitment
20
Inclusion Criteria

• Female
• Sufficient understanding of the German language
• right handed
• Informed consent of the study participant and their legal guardians
• Self-injurious behavior according to the diagnostic criteria of the DSM-V classification (at least five times self-harm without suicidal intention in the past year)
• Age at baseline: 12-17 years
• Treatment at the KJP Regensburg

Exclusion Criteria

• Additional neurological or medical conditions that are believed to influence brain development / physiology
• Pre-existing neurological or endocrine disease
• Taking glucocorticoid-containing medications
• Pregnancy
• intellectual impairment (IQ <80)
• Acute psychotic disorder or acute psychiatric condition, which could affect the ability of patients / volunteers to consent
• acute suicidality
• lack of consent
• MRI-specific contraindications: metallic foreign bodies, tattoos with metallic pigments, claustrophobia, cardiac pacemakers and defibrillator systems, cochlear implants, implanted insulin pumps, non-removable magnetic material piercings.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In-between analysis between two intervention arms pre / post NIRS neurofeedback including fMRI imaging, neurophysiological and psychometric methods.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath